Another autoimmune CAR-T death; Treasury zeroes in on China deals

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 26 Oct, 13:59 UTC

A patient who received Bristol Myers’ zola-cell died 44 days later. Elswehere, Gilead paid nearly $1.3 billion for a potential threat to J&J’s newly approved psoriasis pill.

science

Sources

• T2Another autoimmune CAR-T death; Treasury zeroes in on China dealsBioPharma Dive / Healthcare Dive / MedTech Dive26 Oct, 13:59